Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerardo Botti

Showing results (161-170 of 396) with videos related to

Pageof 40
Sort By:
Japanese Journal of Radiology|July 25, 2018
DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancerAntonella Petrillo, Roberta Fusco, Mario Petrillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2017
Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IPElena Valentino, Arianna Bellazzo, Giulio Di Minin, et al.
BMC Cancer|January 8, 2014
Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomasElena Vigliar, Immacolata Cozzolino, Marco Picardi, et al.
Risk Management and Healthcare Policy|July 16, 2021
Risk Analysis in Healthcare Organizations: Methodological Framework and Critical VariablesGiacomo Pascarella, Matteo Rossi, Emma Montella, et al.
Scientific Reports|May 17, 2019
Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanomaNathalie Harder, Ralf Schönmeyer, Katharina Nekolla, et al.
Journal of Translational Medicine|January 29, 2015
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomasAntonella Manca, Amelia Lissia, Mariaelena Capone, et al.
Oncology|January 26, 2002
A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patientsGiuseppe Frasci, Giuseppe D'Aiuto, Pasquale Comella, et al.
Infectious Agents and Cancer|October 2, 2013
MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomasGabriella Aquino, Laura Marra, Monica Cantile, et al.
Theranostics|November 16, 2018
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamerSimona Camorani, Billy Samuel Hill, Francesca Collina, et al.
The American Journal of Pathology|October 5, 2010
Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomasNicola Amodio, Marianna Scrima, Lucia Palaia, et al.
Pageof 40

Showing results (161-170 of 396) with videos related to

Sort By:
Pageof 40
Japanese Journal of Radiology|July 25, 2018
DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancerAntonella Petrillo, Roberta Fusco, Mario Petrillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2017
Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IPElena Valentino, Arianna Bellazzo, Giulio Di Minin, et al.
BMC Cancer|January 8, 2014
Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomasElena Vigliar, Immacolata Cozzolino, Marco Picardi, et al.
Risk Management and Healthcare Policy|July 16, 2021
Risk Analysis in Healthcare Organizations: Methodological Framework and Critical VariablesGiacomo Pascarella, Matteo Rossi, Emma Montella, et al.
Scientific Reports|May 17, 2019
Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanomaNathalie Harder, Ralf Schönmeyer, Katharina Nekolla, et al.
Journal of Translational Medicine|January 29, 2015
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomasAntonella Manca, Amelia Lissia, Mariaelena Capone, et al.
Oncology|January 26, 2002
A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patientsGiuseppe Frasci, Giuseppe D'Aiuto, Pasquale Comella, et al.
Infectious Agents and Cancer|October 2, 2013
MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomasGabriella Aquino, Laura Marra, Monica Cantile, et al.
Theranostics|November 16, 2018
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamerSimona Camorani, Billy Samuel Hill, Francesca Collina, et al.
The American Journal of Pathology|October 5, 2010
Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomasNicola Amodio, Marianna Scrima, Lucia Palaia, et al.
Pageof 40